All patients with mutations in PKP2 were clinically diagnosed with ARVC according to the revised task force criteria [25], whereas all other patients with mutations in one of the other three genes were initially diagnosed with DCM. This evidence concerns the gene PKP2 and Arrhythmogenic right ventricular dysplasia.